BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fung M, Babik JM. COVID-19 in Immunocompromised Hosts: What We Know So Far. Clin Infect Dis. 2021;72:340-350. [PMID: 33501974 DOI: 10.1093/cid/ciaa863] [Cited by in Crossref: 95] [Cited by in F6Publishing: 99] [Article Influence: 95.0] [Reference Citation Analysis]
Number Citing Articles
1 Jimenez-Kurlander L, Antal Z, DeRosa A, Diotallevi D, Pottenger E, Wilson N, Corcoran S, Boulad F, Friedman DN. COVID-19 in pediatric survivors of childhood cancer and hematopoietic cell transplantation from a single center in New York City. Pediatr Blood Cancer 2021;68:e28857. [PMID: 33355979 DOI: 10.1002/pbc.28857] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
2 Miaskowski C, Paul SM, Snowberg K, Abbott M, Borno H, Chang S, Chen LM, Cohen B, Hammer MJ, Kenfield SA, Kober KM, Levine JD, Pozzar R, Rhoads KF, Van Blarigan EL, Van Loon K. Stress and Symptom Burden in Oncology Patients During the COVID-19 Pandemic. J Pain Symptom Manage 2020;60:e25-34. [PMID: 32889039 DOI: 10.1016/j.jpainsymman.2020.08.037] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
3 Dęborska-Materkowska D, Kamińska D. The Immunology of SARS-CoV-2 Infection and Vaccines in Solid Organ Transplant Recipients. Viruses 2021;13:1879. [PMID: 34578460 DOI: 10.3390/v13091879] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 [DOI: 10.1101/2020.08.07.20169490] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
5 Garbo R, Valent F, Gigli GL, Valente M. Pre-Existing Lymphopenia Increases the Risk of Hospitalization and Death after SARS-CoV-2 Infection. Infectious Disease Reports 2022;14:20-5. [DOI: 10.3390/idr14010003] [Reference Citation Analysis]
6 Ringer M, Azmy V, Kaman K, Tang D, Cheung H, Azar MM, Price C, Malinis M. A retrospective matched cohort single-center study evaluating outcomes of COVID-19 and the impact of immunomodulation on COVID-19-related cytokine release syndrome in solid organ transplant recipients. Transpl Infect Dis 2021;23:e13556. [PMID: 33378571 DOI: 10.1111/tid.13556] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
7 Kopar PK, Kramer JB, Brown DE, Bochicchio GV. Critical Ethics: How to Balance Patient Autonomy With Fairness When Patients Refuse Coronavirus Disease 2019 Testing. Crit Care Explor 2021;3:e0326. [PMID: 33521645 DOI: 10.1097/CCE.0000000000000326] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
8 Mehrabi Nejad M, Moosaie F, Dehghanbanadaki H, Haji Ghadery A, Shabani M, Tabary M, Aryannejad A, Seyedalinaghi S, Rezaei N. Immunogenicity of COVID-19 mRNA vaccines in immunocompromised patients: a systematic review and meta-analysis. Eur J Med Res 2022;27. [DOI: 10.1186/s40001-022-00648-5] [Reference Citation Analysis]
9 Snowden C, Ng S, Choi J. Partial Remission of Advanced Untreated Sezary Syndrome after COVID-19. JAAD Case Rep 2022. [PMID: 35013712 DOI: 10.1016/j.jdcr.2021.12.005] [Reference Citation Analysis]
10 Laothamatas K, Hum J, Benvenuto L, Shah L, Grewal HS, Pereira M, Scheffert J, Carroll M, Nolan M, Reilly G, Lemaitre P, Stanifer BP, Sonett JR, D’ovidio F, Robbins H, Arcasoy SM. One Year Into the Pandemic: Evolving COVID-19 Outcomes in Lung Transplant Recipients, a Single-center Experience. Transplantation Direct 2022;8:e1296. [DOI: 10.1097/txd.0000000000001296] [Reference Citation Analysis]
11 Lynch M, Macori G, Fanning S, O'Regan E, Hunt E, O'Callaghan D, McCullagh B, Jennings C, Fortune A. Genomic Evolution of SARS-CoV-2 Virus in Immunocompromised Patient, Ireland. Emerg Infect Dis 2021;27:2499-501. [PMID: 34161223 DOI: 10.3201/eid2709.211159] [Reference Citation Analysis]
12 Eisinger RW, Lerner AM, Fauci AS. HIV/AIDS in the Era of COVID-19: A Juxtaposition of Two Pandemics. J Infect Dis 2021:jiab114. [PMID: 33825905 DOI: 10.1093/infdis/jiab114] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
13 Bartolomucci A, Sapolsky RM. Psychosocial Risk Factors, Noncommunicable Diseases, and Animal Models for COVID-19. Biol Psychiatry 2021;89:e67-71. [PMID: 33487440 DOI: 10.1016/j.biopsych.2020.12.014] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 Bakouny Z, Hawley JE, Choueiri TK, Peters S, Rini BI, Warner JL, Painter CA. COVID-19 and Cancer: Current Challenges and Perspectives. Cancer Cell 2020;38:629-46. [PMID: 33049215 DOI: 10.1016/j.ccell.2020.09.018] [Cited by in Crossref: 45] [Cited by in F6Publishing: 44] [Article Influence: 22.5] [Reference Citation Analysis]
15 Lledó GM, Sellares J, Brotons C, Sans M, Antón JD, Blanco J, Bassat Q, Sarukhan A, Miró JM, de Sanjosé S; Multidisciplinary Collaborative Group for the Scientific Monitoring of COVID-19 (GCMSC). Post-acute COVID-19 syndrome: a new tsunami requiring a universal case definition. Clin Microbiol Infect 2021:S1198-743X(21)00661-3. [PMID: 34826619 DOI: 10.1016/j.cmi.2021.11.015] [Reference Citation Analysis]
16 Sawyers A, Chou M, Johannet P, Gulati N, Qian Y, Zhong J, Osman I. Clinical outcomes in cancer patients with COVID-19. Cancer Rep (Hoboken) 2021;4:e1413. [PMID: 34409775 DOI: 10.1002/cnr2.1413] [Reference Citation Analysis]
17 Lowe R, Ferrari M, Nasim-Mohi M, Jackson A, Beecham R, Veighey K, Cusack R, Richardson D, Grocott M, Levett D, Dushianthan A; University Hospital Southampton Critical Care Team and the REACT COVID investigators. Clinical characteristics and outcome of critically ill COVID-19 patients with acute kidney injury: a single centre cohort study. BMC Nephrol 2021;22:92. [PMID: 33722189 DOI: 10.1186/s12882-021-02296-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
18 Baek MS, Lee MT, Kim WY, Choi JC, Jung SY. COVID-19-related outcomes in immunocompromised patients: A nationwide study in Korea. PLoS One 2021;16:e0257641. [PMID: 34597325 DOI: 10.1371/journal.pone.0257641] [Reference Citation Analysis]
19 Nijman G, Wientjes M, Ramjith J, Janssen N, Hoogerwerf J, Abbink E, Blaauw M, Dofferhoff T, van Apeldoorn M, Veerman K, de Mast Q, Ten Oever J, Hoefsloot W, Reijers MH, van Crevel R, van de Maat JS. Risk factors for in-hospital mortality in laboratory-confirmed COVID-19 patients in the Netherlands: A competing risk survival analysis. PLoS One 2021;16:e0249231. [PMID: 33770140 DOI: 10.1371/journal.pone.0249231] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
20 Yousaf M, Hameed M, Alsoub H, Khatib M, Jamal W, Ahmad M. COVID-19: Prolonged viral shedding in an HIV patient with literature review of risk factors for prolonged viral shedding and its implications for isolation strategies. Clin Case Rep 2021;9:1397-401. [PMID: 33768853 DOI: 10.1002/ccr3.3786] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
21 Tortolero GA, Brown MR, Sharma SV, de Oliveira Otto MC, Yamal JM, Aguilar D, Gunther MD, Mofleh DI, Harris RD, John JC, de Vries PS, Ramphul R, Serbo DM, Kiger J, Banerjee D, Bonvino N, Merchant A, Clifford W, Mikhail J, Xu H, Murphy RE, Wei Q, Vahidy FS, Morrison AC, Boerwinkle E. Leveraging a health information exchange for analyses of COVID-19 outcomes including an example application using smoking history and mortality. PLoS One 2021;16:e0247235. [PMID: 34081724 DOI: 10.1371/journal.pone.0247235] [Reference Citation Analysis]
22 Bui LT, Winters NI, Chung MI, Joseph C, Gutierrez AJ, Habermann AC, Adams TS, Schupp JC, Poli S, Peter LM, Taylor CJ, Blackburn JB, Richmond BW, Nicholson AG, Rassl D, Wallace WA, Rosas IO, Jenkins RG, Kaminski N, Kropski JA, Banovich NE; Human Cell Atlas Lung Biological Network. Chronic lung diseases are associated with gene expression programs favoring SARS-CoV-2 entry and severity. Nat Commun 2021;12:4314. [PMID: 34262047 DOI: 10.1038/s41467-021-24467-0] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
23 Erber J, Wiessner JR, Huberle C, Schneider J, Mijočević H, von Bomhard D, Luppa P, Schmid RM, Rasch S, Lahmer T. Convalescent plasma therapy in B-cell-depleted and B-cell sufficient patients with life-threatening COVID-19 - A case series. Transfus Apher Sci 2021;:103278. [PMID: 34548246 DOI: 10.1016/j.transci.2021.103278] [Reference Citation Analysis]
24 MacKenzie EL, Hareza DA, Collison MW, Czapar AE, Kraft AK, Waxse BJ, Friedman EE, Ridgway JP. Clinical characteristics of hospitalized patients with false-negative severe acute respiratory coronavirus virus 2 (SARS-CoV-2) test results. Infect Control Hosp Epidemiol 2021;:1-7. [PMID: 33867000 DOI: 10.1017/ice.2021.146] [Reference Citation Analysis]
25 Jacka BP, Phipps E, Marshall BDL. Drug use during a pandemic: Convergent risk of novel coronavirus and invasive bacterial and viral infections among people who use drugs. Int J Drug Policy 2020;83:102895. [PMID: 32741718 DOI: 10.1016/j.drugpo.2020.102895] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
26 Bhaskaran K, Rentsch CT, MacKenna B, Schultze A, Mehrkar A, Bates CJ, Eggo RM, Morton CE, Bacon SCJ, Inglesby P, Douglas IJ, Walker AJ, McDonald HI, Cockburn J, Williamson EJ, Evans D, Forbes HJ, Curtis HJ, Hulme WJ, Parry J, Hester F, Harper S, Evans SJW, Smeeth L, Goldacre B. HIV infection and COVID-19 death: a population-based cohort analysis of UK primary care data and linked national death registrations within the OpenSAFELY platform. Lancet HIV. 2021;8:e24-e32. [PMID: 33316211 DOI: 10.1016/s2352-3018(20)30305-2] [Cited by in Crossref: 54] [Cited by in F6Publishing: 36] [Article Influence: 27.0] [Reference Citation Analysis]
27 Zarei SM, Heydari MR. COVID-19 Crisis, Herbal Medicines, and Natural Products - Concerns and Suggestions. Jundishapur J Nat Pharm Prod 2022;In Press. [DOI: 10.5812/jjnpp-120872] [Reference Citation Analysis]
28 Avina-Galindo AM, Fazal ZA, Marozoff S, Kwan J, Lu N, Hoens AM, Kopec J, Lacaille D, Xie H, Loree JM, Avina-Zubieta JA; SCOUT team. Immunosuppression and COVID-19 infection in British Columbia: Protocol for a linkage study of population-based administrative and self-reported survey data. PLoS One 2021;16:e0259601. [PMID: 34797824 DOI: 10.1371/journal.pone.0259601] [Reference Citation Analysis]
29 Gatti M, Rinaldi M, Bussini L, Bonazzetti C, Pascale R, Pasquini Z, Faní F, Pinho Guedes MN, Azzini AM, Carrara E, Palacios-baena ZR, Caponcello G, Reyna-villasmil E, Tacconelli E, Rodríguez-baño J, Viale P, Giannella M, Caroccia N, Arbizzani F, Giacomini ME, Vatamanu O, Razzaboni E, De Rui ME, Gorska A, Maldonado N, Olivares P, Gutiérrez-campos D, Martín-gutiérrez AB, Palomo V, Serna A. Clinical outcome in solid organ transplant recipients affected by COVID-19 compared to general population: a systematic review and meta-analysis. Clinical Microbiology and Infection 2022. [DOI: 10.1016/j.cmi.2022.02.039] [Reference Citation Analysis]
30 Howland S, Deuring JJ, Zhou X, Chen Y, Mota LM, Ungaro RC. Tofacitinib Use in Adults with Chronic Inflammatory Disease During the Severe Acute Respiratory Syndrome Coronavirus 2 Pandemic: What Is Known So Far? Curr Ther Res Clin Exp 2021;95:100639. [PMID: 34334801 DOI: 10.1016/j.curtheres.2021.100639] [Reference Citation Analysis]
31 Fernández Ibáñez JM, Morales Ballesteros MDC, Galindo Andúgar MÁ, Fernández Anguita MJ, Arias Arias Á, Barberá-Farré JR. [Risk factors for mortality in patients over 65 years old hospitalized by COVID-19]. Rev Esp Geriatr Gerontol 2021:S0211-139X(21)00176-1. [PMID: 34924215 DOI: 10.1016/j.regg.2021.09.004] [Reference Citation Analysis]
32 Burack D, Pereira MR, Tsapepas DS, Harren P, Farr MA, Arcasoy S, Cohen DJ, Mohan S, Emond JC, Hod EA, Verna EC. Prevalence and predictors of SARS-CoV-2 antibodies among solid organ transplant recipients with confirmed infection. Am J Transplant 2021;21:2254-61. [PMID: 33590675 DOI: 10.1111/ajt.16541] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 11.0] [Reference Citation Analysis]
33 Ibrahim M, Vegel A, Niu A, Panse K, Chen R, Safah H, Socola F, Luk A, Saba NS. Reinfection versus failure of viral clearance in a COVID-19 patient with hematologic malignancy. Leuk Res 2021;101:106514. [PMID: 33524639 DOI: 10.1016/j.leukres.2021.106514] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 Brehm TT, van der Meirschen M, Hennigs A, Roedl K, Jarczak D, Wichmann D, Frings D, Nierhaus A, Oqueka T, Fiedler W, Christopeit M, Kraef C, Schultze A, Lütgehetmann M, Addo MM, Schmiedel S, Kluge S, Schulze Zur Wiesch J. Comparison of clinical characteristics and disease outcome of COVID-19 and seasonal influenza. Sci Rep 2021;11:5803. [PMID: 33707550 DOI: 10.1038/s41598-021-85081-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
35 Landes SD, Turk MA, Damiani MR, Proctor P, Baier S. Risk Factors Associated With COVID-19 Outcomes Among People With Intellectual and Developmental Disabilities Receiving Residential Services. JAMA Netw Open 2021;4:e2112862. [PMID: 34100935 DOI: 10.1001/jamanetworkopen.2021.12862] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
36 Hsu CM, Weiner DE, Aweh G, Miskulin DC, Manley HJ, Stewart C, Ladik V, Hosford J, Lacson EC, Johnson DS, Lacson E Jr. COVID-19 Among US Dialysis Patients: Risk Factors and Outcomes From a National Dialysis Provider.Am J Kidney Dis. 2021;77:748-756.e1. [PMID: 33465417 DOI: 10.1053/j.ajkd.2021.01.003] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 25.0] [Reference Citation Analysis]
37 Haidar G, Mellors JW. Improving the Outcomes of Immunocompromised Patients with COVID-19. Clin Infect Dis 2021:ciab397. [PMID: 33949644 DOI: 10.1093/cid/ciab397] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
38 Yoke LH, Lee JM, Krantz EM, Morris J, Marquis S, Bhattacharyya P, So L, Riedo FX, Simmons J, Khaki AR, Cheng GS, Greninger AL, Pergam SA, Waghmare A, Ogimi C, Liu C. Clinical and Virologic Characteristics and Outcomes of Coronavirus Disease 2019 at a Cancer Center. Open Forum Infect Dis 2021;8:ofab193. [PMID: 34183982 DOI: 10.1093/ofid/ofab193] [Reference Citation Analysis]
39 Marra AR, Kobayashi T, Suzuki H, Alsuhaibani M, Tofaneto BM, Bariani LM, Auler MA, Salinas JL, Edmond MB, Doll M, Kutner JM, Pinho JRR, Rizzo LV, Miraglia JL, Schweizer ML. Short-term effectiveness of COVID-19 vaccines in immunocompromised patients: A systematic literature review and meta-analysis. J Infect 2022:S0163-4453(21)00658-7. [PMID: 34982962 DOI: 10.1016/j.jinf.2021.12.035] [Reference Citation Analysis]
40 Lashgari NA, Momeni Roudsari N, Momtaz S, Abdolghaffari AH. Transmembrane serine protease 2 and angiotensin-converting enzyme 2 anti-inflammatory receptors for COVID-19/inflammatory bowel diseases treatment. World J Gastroenterol 2021; 27(46): 7943-7955 [DOI: 10.3748/wjg.v27.i46.7943] [Reference Citation Analysis]
41 Chiarucci M, Paolasini S, Isidori A, Guiducci B, Loscocco F, Capalbo M, Visani G. Immunological Response Against SARS-COV-2 After BNT162b2 Vaccine Administration Is Impaired in Allogeneic but Not in Autologous Stem Cell Transplant Recipients. Front Oncol 2021;11:737300. [PMID: 34552880 DOI: 10.3389/fonc.2021.737300] [Reference Citation Analysis]
42 Piechotta V, Iannizzi C, Chai KL, Valk SJ, Kimber C, Dorando E, Monsef I, Wood EM, Lamikanra AA, Roberts DJ, McQuilten Z, So-Osman C, Estcourt LJ, Skoetz N. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review. Cochrane Database Syst Rev 2021;5:CD013600. [PMID: 34013969 DOI: 10.1002/14651858.CD013600.pub4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]
43 Boadi-Kusi SB, Kyei S, Ocansey S, Ntodie M, Ofori-Agyei DB, Mashige KP. Assessment of infection prevention and control measures adopted by eye care practitioners in Ghana and South Africa against COVID-19. Sci Afr 2021;12:e00766. [PMID: 33997540 DOI: 10.1016/j.sciaf.2021.e00766] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
44 Gu S, Chen Y, Lv L, Li L. Reply to Marcialis et al. Clin Infect Dis 2021;72:2246-7. [PMID: 32645719 DOI: 10.1093/cid/ciaa966] [Reference Citation Analysis]
45 Yang Y, Iwasaki A. Impact of Chronic HIV Infection on SARS-CoV-2 Infection, COVID-19 Disease and Vaccines. Curr HIV/AIDS Rep 2021. [PMID: 34843064 DOI: 10.1007/s11904-021-00590-x] [Reference Citation Analysis]
46 Migo W, Boskovic M, Likic R. The development of biologics to target SARS-CoV2: Treatment potential of antibodies in patient groups with poor immune response. Curr Res Pharmacol Drug Discov 2021;2:100064. [PMID: 34870159 DOI: 10.1016/j.crphar.2021.100064] [Reference Citation Analysis]
47 Kato H, Asano Y, Arakawa S, Ito M, Kawabe N, Shimura M, Hayashi C, Ochi T, Yasuoka H, Higashiguchi T, Kondo Y, Nagata H, Horiguchi A. Surgery for pancreatic tumors in the midst of COVID-19 pandemic. World J Clin Cases 2021; 9(18): 4460-4466 [PMID: 34222414 DOI: 10.12998/wjcc.v9.i18.4460] [Reference Citation Analysis]
48 Peter AE, Sandeep BV, Rao BG, Kalpana VL. Nanotechnology to the Rescue: Treatment Perspective for the Immune Dysregulation Observed in COVID-19. Front Nanotechnol 2021;3:644023. [DOI: 10.3389/fnano.2021.644023] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
49 Kumric M, Ticinovic Kurir T, Martinovic D, Zivkovic PM, Bozic J. Impact of the COVID-19 pandemic on inflammatory bowel disease patients: A review of the current evidence. World J Gastroenterol 2021; 27(25): 3748-3761 [PMID: 34321841 DOI: 10.3748/wjg.v27.i25.3748] [Reference Citation Analysis]
50 Dakowitz M, Korus J, Mazanowska O, Krajewska M, Kamińska D. Co-Infection of COVID-19 and Pneumocystosis Following Rituximab Infusion—A Case Report. Transplantology 2022;3:83-90. [DOI: 10.3390/transplantology3010008] [Reference Citation Analysis]
51 Shaunak M, Patel R, Driessens C, Mills L, Leahy A, Gbesemete D, Owens DR, Lucas JS, Faust SN, de Graaf H; ImmunoCOVID19 study group. COVID-19 symptom surveillance in immunocompromised children and young people in the UK: a prospective observational cohort study. BMJ Open 2021;11:e044899. [PMID: 33737439 DOI: 10.1136/bmjopen-2020-044899] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
52 Pereira MR, Arcasoy S, Farr MA, Mohan S, Emond JC, Tsapepas DS, Shi Q, Purpura L, Uhlemann AC, Zucker J, Verna EC. Outcomes of COVID-19 in solid organ transplant recipients: A matched cohort study. Transpl Infect Dis 2021;:e13637. [PMID: 33993630 DOI: 10.1111/tid.13637] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
53 Vallée A, Fourn E, Majerholc C, Touche P, Zucman D. COVID-19 Vaccine Hesitancy among French People Living with HIV. Vaccines (Basel) 2021;9:302. [PMID: 33804808 DOI: 10.3390/vaccines9040302] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
54 Agha ME, Blake M, Chilleo C, Wells A, Haidar G. Suboptimal Response to Coronavirus Disease 2019 Messenger RNA Vaccines in Patients With Hematologic Malignancies: A Need for Vigilance in the Postmasking Era. Open Forum Infect Dis 2021;8:ofab353. [PMID: 34337100 DOI: 10.1093/ofid/ofab353] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
55 Nailescu C, Khalid M, Wilson AC, Amanat F, Arregui S, Canas J, Hooks J, Krammer F, Schwaderer AL, Hains DS. Assessment of Seroconversion to SARS-CoV-2 in a Cohort of Pediatric Kidney Transplant Recipients. Front Pediatr 2020;8:601327. [PMID: 33194930 DOI: 10.3389/fped.2020.601327] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
56 Hermel DJ, Spierling Bagsic SR, Costantini CL, Mason JR, Gahvari ZJ, Saven A. ABO phenotype and clinical correlates of COVID-19 severity in hospitalized patients. Future Sci OA 2021;7:FSO735. [PMID: 34290882 DOI: 10.2144/fsoa-2021-0045] [Reference Citation Analysis]
57 Reimann P, Ulmer H, Mutschlechner B, Benda M, Severgnini L, Volgger A, Lang T, Atzl M, Huynh M, Gasser K, Grabher C, Mink S, Fraunberger P, Petrausch U, Hartmann B, Winder T. Efficacy and safety of heterologous booster vaccination with Ad26.COV2.S after BNT162b2 mRNA COVID-19 vaccine in haemato-oncological patients with no antibody response. Br J Haematol 2021. [PMID: 34872162 DOI: 10.1111/bjh.17982] [Reference Citation Analysis]
58 Friedman EE, Devlin SA, McNulty MC, Ridgway JP. SARS-CoV-2 percent positivity and risk factors among people with HIV at an urban academic medical center. PLoS One 2021;16:e0254994. [PMID: 34288954 DOI: 10.1371/journal.pone.0254994] [Reference Citation Analysis]
59 Connelly JA, Chong H, Esbenshade AJ, Frame D, Failing C, Secord E, Walkovich K. Impact of COVID-19 on Pediatric Immunocompromised Patients. Pediatr Clin North Am 2021;68:1029-54. [PMID: 34538297 DOI: 10.1016/j.pcl.2021.05.007] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
60 Lin Z, Chen J, Han S. Impact of anti-cancer therapy on disease severity and mortality in cancer patients with COVID-19: a systematic review and meta-analysis. Expert Rev Anticancer Ther 2021;21:1055-66. [PMID: 33970745 DOI: 10.1080/14737140.2021.1927721] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
61 Dreyer N, Petruski-Ivleva N, Albert L, Mohamed D, Brinkley E, Reynolds M, Toovey S. Identification of a Vulnerable Group for Post-Acute Sequelae of SARS-CoV-2 (PASC): People with Autoimmune Diseases Recover More Slowly from COVID-19. Int J Gen Med 2021;14:3941-9. [PMID: 34345182 DOI: 10.2147/IJGM.S313486] [Reference Citation Analysis]
62 Van Damme KFA, Tavernier S, Van Roy N, De Leeuw E, Declercq J, Bosteels C, Maes B, De Bruyne M, Bogaert D, Bosteels V, Hoste L, Naesens L, Maes P, Grifoni A, Weiskopf D, Sette A, Depuydt P, Van Braeckel E, Haerynck F, Lambrecht BN. Case Report: Convalescent Plasma, a Targeted Therapy for Patients with CVID and Severe COVID-19. Front Immunol 2020;11:596761. [PMID: 33329586 DOI: 10.3389/fimmu.2020.596761] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
63 Giannella M, Righi E, Pascale R, Rinaldi M, Caroccia N, Gamberini C, Palacios-baena ZR, Caponcello G, Morelli MC, Tamè M, Busutti M, Comai G, Potena L, Salvaterra E, Feltrin G, Cillo U, Gerosa G, Cananzi M, Piano S, Benetti E, Burra P, Loy M, Furian L, Zaza G, Onorati F, Carraro A, Gastaldon F, Nordio M, Kumar-singh S, Abedini M, Boffetta P, Rodríguez-baño J, Lazzarotto T, Viale P, Tacconelli E; on behalf of The ORCHESTRA Study Group Workpackage. Evaluation of the Kinetics of Antibody Response to COVID-19 Vaccine in Solid Organ Transplant Recipients: The Prospective Multicenter ORCHESTRA Cohort. Microorganisms 2022;10:1021. [DOI: 10.3390/microorganisms10051021] [Reference Citation Analysis]
64 Merchant EA, Flint K, Barouch DH, Blair BM. Co-infection with coronavirus disease 2019, previously undiagnosed human immunodeficiency virus, Pneumocystis jirovecii pneumonia and cytomegalovirus pneumonitis, with possible immune reconstitution inflammatory syndrome. IDCases 2021;24:e01153. [PMID: 33977081 DOI: 10.1016/j.idcr.2021.e01153] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
65 Choi EM. COVID-19 vaccines for low- and middle-income countries. Trans R Soc Trop Med Hyg 2021;115:447-56. [PMID: 33733663 DOI: 10.1093/trstmh/trab045] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
66 Udomkarnjananun S, Kerr SJ, Townamchai N, Susantitaphong P, Tulvatana W, Praditpornsilpa K, Eiam-Ong S, Avihingsanon Y. Mortality risk factors of COVID-19 infection in kidney transplantation recipients: a systematic review and meta-analysis of cohorts and clinical registries. Sci Rep 2021;11:20073. [PMID: 34625642 DOI: 10.1038/s41598-021-99713-y] [Reference Citation Analysis]
67 Jeong SH, Kim YS. Challenges in Prescribing Clozapine in the Era of COVID-19: A Review Focused on Immunological Implications. Clin Psychopharmacol Neurosci 2021;19:411-22. [PMID: 34294611 DOI: 10.9758/cpn.2021.19.3.411] [Reference Citation Analysis]
68 Algwaiz G, Aljurf M, Koh M, Horowitz MM, Ljungman P, Weisdorf D, Saber W, Kodera Y, Szer J, Jawdat D, Wood WA, Brazauskas R, Lehmann L, Pasquini MC, Seber A, Lu PH, Atsuta Y, Riches M, Perales MA, Worel N, Okamoto S, Srivastava A, Chemaly RF, Cordonnier C, Dandoy CE, Wingard JR, Kharfan-Dabaja MA, Hamadani M, Majhail NS, Waghmare AA, Chao N, Kröger N, Shaw B, Mohty M, Niederwieser D, Greinix H, Hashmi SK; WBMT and the CIBMTR Health Services and International Studies Committee. Real-World Issues and Potential Solutions in Hematopoietic Cell Transplantation during the COVID-19 Pandemic: Perspectives from the Worldwide Network for Blood and Marrow Transplantation and Center for International Blood and Marrow Transplant Research Health Services and International Studies Committee. Biol Blood Marrow Transplant 2020;26:2181-9. [PMID: 32717432 DOI: 10.1016/j.bbmt.2020.07.021] [Cited by in Crossref: 15] [Cited by in F6Publishing: 20] [Article Influence: 7.5] [Reference Citation Analysis]
69 Johnston EE, Martinez I, Davis ES, Caudill C, Richman J, Brackett J, Dickens DS, Kahn A, Schwalm C, Sharma A, Patel PA, Bhatia S, Levine JM, Wolfson JA; POCC Consortium. SARS-CoV-2 in Childhood Cancer in 2020: A Disease of Disparities. J Clin Oncol 2021;39:3778-88. [PMID: 34694886 DOI: 10.1200/JCO.21.00702] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
70 Thanou A, Sawalha AH. SARS-CoV-2 and Systemic Lupus Erythematosus. Curr Rheumatol Rep 2021;23:8. [PMID: 33511495 DOI: 10.1007/s11926-020-00973-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
71 Arevalo YA, Murillo AL, Ho EW, Advani SM, Davis L, Lipsey AF, Kim M, Waterman AD. Stressors and Information-Seeking by Dialysis and Transplant Patients During COVID-19 Reported on a Telephone Hotline: A Mixed Methods Study. Kidney Medicine 2022. [DOI: 10.1016/j.xkme.2022.100479] [Reference Citation Analysis]
72 Howden K, Glidden C, Romanescu RG, Hatala A, Scott I, Deleemans J, Chalifour K, Eaton G, Gupta AA, Bolton JM, Mahar AL, Garland SN, Oberoi S. A Cross-Sectional Survey Exploring the Impact of the COVID-19 Pandemic on the Cancer Care of Adolescents and Young Adults. Curr Oncol 2021;28:3201-13. [PMID: 34436044 DOI: 10.3390/curroncol28040278] [Reference Citation Analysis]
73 Singer PS, Sethna C, Molmenti E, Fahmy A, Grodstein E, Castellanos-Reyes L, Fassano J, Teperman L. COVID-19 infection in a pediatric kidney transplant population: A single-center experience. Pediatr Transplant 2021;25:e14018. [PMID: 33813782 DOI: 10.1111/petr.14018] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
74 Bui LT, Winters NI, Chung MI, Joseph C, Gutierrez AJ, Habermann AC, Adams TS, Schupp JC, Poli S, Peter LM, Taylor CJ, Blackburn JB, Richmond BW, Nicholson AG, Rassl D, Wallace WA, Rosas IO, Jenkins RG, Kaminski N, Kropski JA, Banovich NE; Human Cell Atlas Lung Biological Network . Chronic lung diseases are associated with gene expression programs favoring SARS-CoV-2 entry and severity. bioRxiv 2021:2020. [PMID: 33106805 DOI: 10.1101/2020.10.20.347187] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
75 Spinicci M, Mazzoni A, Borchi B, Graziani L, Mazzetti M, Bartalesi F, Botta A, Tilli M, Pieralli F, Coppi M, Giovacchini N, Colao MG, Saccardi R, Rossolini GM, Annunziato F, Bartoloni A. AIDS patient with severe T cell depletion achieved control but not clearance of SARS-CoV-2 infection. Eur J Immunol 2021. [PMID: 34822185 DOI: 10.1002/eji.202149574] [Reference Citation Analysis]
76 Bertagnolio S, Thwin SS, Silva R, Nagarajan S, Jassat W, Fowler R, Haniffa R, Reveiz L, Ford N, Doherty M, Diaz J. Clinical features of, and risk factors for, severe or fatal COVID-19 among people living with HIV admitted to hospital: analysis of data from the WHO Global Clinical Platform of COVID-19. The Lancet HIV 2022. [DOI: 10.1016/s2352-3018(22)00097-2] [Reference Citation Analysis]
77 Damázio LODA, Lins EM, Ferraz ÁAB, Bezerra CDM, Carvalho Neto FACB, Oliveira LLRD, Costa MCSD, Santos PMC. Padrões tomográficos de agentes etiológicos da pneumonia durante o primeiro ano após transplante renal. Radiol Bras 2022;55:84-9. [DOI: 10.1590/0100-3984.2021.0069] [Reference Citation Analysis]
78 Kishk A, Pacheco MP, Sauter T. DCcov: Repositioning of drugs and drug combinations for SARS-CoV-2 infected lung through constraint-based modeling. iScience 2021;24:103331. [PMID: 34723158 DOI: 10.1016/j.isci.2021.103331] [Reference Citation Analysis]
79 Kravitz MB, Yakubova E, Yu N, Park SY. Severity of Sleep Apnea and COVID-19 Illness. OTO Open 2021;5:2473974X211016283. [PMID: 34036239 DOI: 10.1177/2473974X211016283] [Reference Citation Analysis]
80 Akinosoglou K, Paliogianni F, Spyridonidis A, Symeonidis A, Alexopoulos LG, Ziazias D, Kouraklis-Symeonidis A, Marangos M, Gogos C. SARS-CoV-2 persistence and non-protective immunity in infected haematological patients. Br J Haematol 2021;192:e51-4. [PMID: 33216364 DOI: 10.1111/bjh.17212] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
81 Mangge H, Kneihsl M, Schnedl W, Sendlhofer G, Curcio F, Domenis R. Immune Responses against SARS-CoV-2-Questions and Experiences. Biomedicines 2021;9:1342. [PMID: 34680460 DOI: 10.3390/biomedicines9101342] [Reference Citation Analysis]
82 Wehrle CJ, Lee SW, Devarakonda AK, Arora TK. Patient and Physician Attitudes Toward Telemedicine in Cancer Clinics Following the COVID-19 Pandemic. JCO Clin Cancer Inform 2021;5:394-400. [PMID: 33822651 DOI: 10.1200/CCI.20.00183] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
83 Maher KR, Bouligny IM, Yeager AM. Prevention and management of infections after exposure to ionising radiation. J Radiol Prot 2021;41. [PMID: 34265748 DOI: 10.1088/1361-6498/ac14d3] [Reference Citation Analysis]
84 Chamilos G, Lionakis MS, Kontoyiannis DP. Are All Patients with Cancer at Heightened Risk for Severe Coronavirus Disease 2019 (COVID-19)? Clin Infect Dis 2021;72:351-6. [PMID: 33501958 DOI: 10.1093/cid/ciaa1079] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
85 Fischer N, Dauby N, Bossuyt N, Reynders M, Gérard M, Lacor P, Daelemans S, Lissoir B, Holemans X, Magerman K, Jouck D, Bourgeois M, Delaere B, Quoilin S, Van Gucht S, Thomas I, Barbezange C, Subissi L. Monitoring of human coronaviruses in Belgian primary care and hospitals, 2015-20: a surveillance study. Lancet Microbe 2021;2:e105-14. [PMID: 33937883 DOI: 10.1016/S2666-5247(20)30221-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
86 Ünsal O, Yazıcı O, Özdemir N, Çubukçu E, Ocak B, Üner A, Özet A. Clinical and laboratory outcomes of the solid cancer patients reinfected with SARS-CoV-2. Future Oncol 2021. [PMID: 34825831 DOI: 10.2217/fon-2021-0621] [Reference Citation Analysis]
87 Mardani M, Hakamifard A. COVID-19 and immunocompromised conditions: Ongoing challenging issue. Eur J Inflamm 2021;19:205873922110161. [DOI: 10.1177/20587392211016114] [Reference Citation Analysis]
88 Karaba AH, Zhu X, Liang T, Wang KH, Rittenhouse AG, Akinde O, Eby Y, Ruff JE, Blankson JN, Abedon AT, Alejo JL, Cox AL, Bailey JR, Thompson EA, Klein SL, Warren DS, Garonzik-Wang JM, Boyarsky BJ, Sitaras I, Pekosz A, Segev DL, Tobian AAR, Werbel WA. A Third Dose of SARS-CoV-2 Vaccine Increases Neutralizing Antibodies Against Variants of Concern in Solid Organ Transplant Recipients. medRxiv 2021:2021. [PMID: 34671774 DOI: 10.1101/2021.08.11.21261914] [Reference Citation Analysis]
89 Ilinca AP, Dakhallah N, Souza AM, Liu J, Bérubé S, Brossard J, Vézina C, Pelland-Marcotte MC, Santiago R, Tran TH. Clinical characteristics and outcomes of SARS-CoV-2 infection in pediatric oncology patients in the province of Quebec. Pediatr Blood Cancer 2022;:e29572. [PMID: 35084108 DOI: 10.1002/pbc.29572] [Reference Citation Analysis]
90 Fung M, Otani I, Pham M, Babik J. Zoonotic coronavirus epidemics: Severe acute respiratory syndrome, Middle East respiratory syndrome, and coronavirus disease 2019. Ann Allergy Asthma Immunol 2021;126:321-37. [PMID: 33310180 DOI: 10.1016/j.anai.2020.11.021] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
91 Alshukairi AN, Tolah AM, Dada A, Al-Tawfiq JA, Almagharbi RS, Saeedi MF, Al-Hamzi MA, El-Kafrawy SA, Bahaudden HA, El-Saed A, Al-Mozaini MA, Khalid I, Hefni LK, Hassan AM, Alandijany TA, Bajrai LH, Bayumi DT, Albishi GE, Althawadi SI, Zabani NA, Perlman S, Azhar EI. Test-based de-isolation in COVID-19 immunocompromised patients: Cycle threshold value versus SARS-CoV-2 viral culture. Int J Infect Dis 2021;108:112-5. [PMID: 34004329 DOI: 10.1016/j.ijid.2021.05.027] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
92 Downes KJ, Danziger-Isakov LA, Cousino MK, Green M, Michaels MG, Muller WJ, Orscheln RC, Sharma TS, Statler VA, Wattier RL, Ardura MI. Return to School for Pediatric Solid Organ Transplant Recipients in the United States During the Coronavirus Disease 2019 Pandemic: Expert Opinion on Key Considerations and Best Practices. J Pediatric Infect Dis Soc 2020;9:551-63. [PMID: 32750142 DOI: 10.1093/jpids/piaa095] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
93 Su HY, Hsu YC. Patients with cirrhosis during the COVID-19 pandemic: Current evidence and future perspectives . World J Clin Cases 2021; 9(13): 2951-2968 [PMID: 33969082 DOI: 10.12998/wjcc.v9.i13.2951] [Reference Citation Analysis]
94 Brehm TT, van der Meirschen M, Hennigs A, Roedl K, Jarczak D, Wichmann D, Frings D, Nierhaus A, Oqueka T, Fiedler W, Christopeit M, Kraef C, Schultze A, Lütgehetmann M, Addo MM, Schmiedel S, Kluge S, Schulze Zur Wiesch J. Comparison of clinical characteristics and disease outcome of COVID-19 and seasonal influenza. Sci Rep 2021;11:5803. [PMID: 33707550 DOI: 10.1038/s41598-021-85081-0] [Cited by in Crossref: 16] [Cited by in F6Publishing: 1] [Article Influence: 16.0] [Reference Citation Analysis]
95 Waters LJ, Pozniak AL. COVID-19 death in people with HIV: interpret cautiously. Lancet HIV 2021;8:e2-3. [PMID: 33316210 DOI: 10.1016/S2352-3018(20)30332-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 3.5] [Reference Citation Analysis]
96 Baksh RA, Pape SE, Smith J, Strydom A. Understanding inequalities in COVID-19 outcomes following hospital admission for people with intellectual disability compared to the general population: a matched cohort study in the UK. BMJ Open 2021;11:e052482. [PMID: 34607870 DOI: 10.1136/bmjopen-2021-052482] [Reference Citation Analysis]
97 Yang X, Sun J, Patel RC, Zhang J, Guo S, Zheng Q, Olex AL, Olatosi B, Weissman SB, Islam JY, Chute CG, Haendel M, Kirk GD, Li X; National COVID Cohort Collaborative Consortium. Associations between HIV infection and clinical spectrum of COVID-19: a population level analysis based on US National COVID Cohort Collaborative (N3C) data. Lancet HIV 2021;8:e690-700. [PMID: 34655550 DOI: 10.1016/S2352-3018(21)00239-3] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
98 Verma AK, Beg MMA, Bhatt D, Dev K, Alsahli MA, Rahmani AH, Goyal Y. Assessment and Management of Diabetic Patients During the COVID-19 Pandemic. Diabetes Metab Syndr Obes 2021;14:3131-46. [PMID: 34262317 DOI: 10.2147/DMSO.S285614] [Reference Citation Analysis]
99 Ghazizadeh Esslami G, Mamishi S, Mahmoudi S, Navaeian A, Behfar M, Hamidieh AA, Alimadadi H, Mahmoudieh Y. COVID-19 in transplant recipient children: An Iranian referral hospital-based study. Acta Biomed 2021;92:e2021095. [PMID: 33988141 DOI: 10.23750/abm.v92i2.11189] [Reference Citation Analysis]
100 Eilami O, Lopes MIBF, Gryschek RCB, Taghipour K. A case report of COVID-19 in a patient with non-Hodgkin's lymphoma. BMC Infect Dis 2021;21:809. [PMID: 34384365 DOI: 10.1186/s12879-021-06472-2] [Reference Citation Analysis]
101 Krejci M, Pour L, Adam Z, Sandecka V, Stork M, Sevcikova S, Krejci M, Knechtova Z, Kral Z. Outcome of COVID-19 infection in 50 multiple myeloma patients treated with novel drugs: single-center experience. Ann Hematol 2021. [PMID: 34309714 DOI: 10.1007/s00277-021-04594-w] [Reference Citation Analysis]
102 Gill I, Shaheen AA, Edhi AI, Amin M, Rana K, Cappell MS. Novel Case Report: A Previously Reported, but Pathophysiologically Unexplained, Association Between Collagenous Colitis and Protein-Losing Enteropathy May Be Explained by an Undetected Link with Collagenous Duodenitis. Dig Dis Sci 2021. [PMID: 33537921 DOI: 10.1007/s10620-020-06804-3] [Reference Citation Analysis]
103 Nomoto H, Suzuki S, Asai Y, Hayakawa K, Gatanaga H, Terada M, Suzuki K, Ohtsu H, Toyoda A, Ohmagari N. Clinical characteristics and prognosis of immunosuppressed inpatients with COVID-19 in Japan. J Infect Chemother 2021:S1341-321X(21)00294-4. [PMID: 34776348 DOI: 10.1016/j.jiac.2021.10.021] [Reference Citation Analysis]
104 Kamdar KY, Kim TO, Doherty EE, Pfeiffer TM, Qasim SL, Suell MN, Yates AM, Blaney SM. COVID-19 outcomes in a large pediatric hematology-oncology center in Houston, Texas. Pediatr Hematol Oncol 2021;:1-14. [PMID: 34032552 DOI: 10.1080/08880018.2021.1924327] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
105 Yekedüz E, Utkan G, Ürün Y. A systematic review and meta-analysis: the effect of active cancer treatment on severity of COVID-19. Eur J Cancer 2020;141:92-104. [PMID: 33130550 DOI: 10.1016/j.ejca.2020.09.028] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 11.5] [Reference Citation Analysis]
106 Aroniadis OC, Wang X, Gong T, Forbes N, Yang JY, Canakis A, Elmunzer BJ, Yadav D; North American Alliance for the Study of Digestive Manifestations of Covid-19. Factors Associated with the Development of Gastrointestinal Symptoms in Patients Hospitalized with Covid-19. Dig Dis Sci 2021. [PMID: 34751837 DOI: 10.1007/s10620-021-07286-7] [Reference Citation Analysis]
107 Lee H, Chang MC. YouTube as a source of information regarding the effect of vitamin C on coronavirus disease. Complementary Therapies in Medicine 2022;67:102827. [DOI: 10.1016/j.ctim.2022.102827] [Reference Citation Analysis]
108 Young-Xu Y, Korves C, Roberts J, Powell EI, Zwain GM, Smith J, Izurieta HS. Coverage and Estimated Effectiveness of mRNA COVID-19 Vaccines Among US Veterans. JAMA Netw Open 2021;4:e2128391. [PMID: 34613401 DOI: 10.1001/jamanetworkopen.2021.28391] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
109 Oh TK, Song IA, Lee J, Eom W, Jeon YT. Musculoskeletal Disorders, Pain Medication, and in-Hospital Mortality among Patients with COVID-19 in South Korea: A Population-Based Cohort Study. Int J Environ Res Public Health 2021;18:6804. [PMID: 34202825 DOI: 10.3390/ijerph18136804] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
110 Parisi C. An Opportunity to Better Understand the Impact of Coronaviruses on Immunocompromised Patients. J Infect Dis 2021;224:372-3. [PMID: 33220053 DOI: 10.1093/infdis/jiaa720] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
111 Friedman MR, Kempf MC, Benning L, Adimora AA, Aouizerat B, Cohen MH, Hatfield Q, Merenstein D, Mimiaga MJ, Plankey MW, Sharma A, Sheth AN, Ramirez C, Stosor V, Wagner MCE, Wilson TE, D'Souza G, Weiss DJ. Prevalence of COVID-19-Related Social Disruptions and Effects on Psychosocial Health in a Mixed-Serostatus Cohort of Men and Women. J Acquir Immune Defic Syndr 2021;88:426-38. [PMID: 34757972 DOI: 10.1097/QAI.0000000000002799] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
112 Alexandra VU, Sebastian W, Nathalie M, Angela L, Jean-Corentin S, Chloé S. SARS-CoV-2 infection in hematological patients during allogenic stem cell transplantation: A double case report. Clin Case Rep 2021;9:e04439. [PMID: 34295477 DOI: 10.1002/ccr3.4439] [Reference Citation Analysis]
113 Nakayama M, Okada AA, Hayashi I, Ando Y, Watanabe T, Keino H. A COVID-19 Risk Reduction Strategy for the Treatment of Acute Vogt-Koyanagi-Harada Disease Utilizing the Antiviral Potential of Cyclosporine. Ocul Immunol Inflamm 2022;:1-6. [PMID: 35167414 DOI: 10.1080/09273948.2022.2028293] [Reference Citation Analysis]
114 Howden K, Yan AP, Glidden C, Romanescu RG, Scott I, Deleemans JM, Chalifour K, Eaton G, Gupta AA, Bolton JM, Garland SN, Mahar AL, Oberoi S. Loneliness among adolescents and young adults with cancer during the COVID-19 pandemic: a cross-sectional survey. Support Care Cancer 2021. [PMID: 34708310 DOI: 10.1007/s00520-021-06628-5] [Reference Citation Analysis]
115 Sahoo S, Jhunjhunwala S, Jolly MK. The Good, The Bad and The Ugly: A Mathematical Model Investigates the Differing Outcomes Among CoVID-19 Patients. J Indian Inst Sci 2020;:1-9. [PMID: 33041543 DOI: 10.1007/s41745-020-00205-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
116 Simeunovic Ostojic M, Maas J, Bodde NMG. COVID-19, anorexia nervosa and obese patients with an eating disorder - some considerations for practitioners and researchers. J Eat Disord 2021;9:15. [PMID: 33472682 DOI: 10.1186/s40337-021-00369-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
117 Agha M, Blake M, Chilleo C, Wells A, Haidar G. Suboptimal response to COVID-19 mRNA vaccines in hematologic malignancies patients. medRxiv 2021:2021. [PMID: 33851182 DOI: 10.1101/2021.04.06.21254949] [Cited by in Crossref: 15] [Cited by in F6Publishing: 6] [Article Influence: 15.0] [Reference Citation Analysis]
118 Kates OS, Diekema DS, Blumberg EA. Should Health Care Institutions Mandate SARS-CoV-2 Vaccination for Staff? Open Forum Infect Dis 2021;8:ofab155. [PMID: 34183980 DOI: 10.1093/ofid/ofab155] [Reference Citation Analysis]
119 Budu MO, Rugel EJ, Nocos R, Teo K, Rangarajan S, Lear SA. Psychological Impact of COVID-19 on People with Pre-Existing Chronic Disease. Int J Environ Res Public Health 2021;18:5972. [PMID: 34199516 DOI: 10.3390/ijerph18115972] [Reference Citation Analysis]
120 Belsky JA, Tullius BP, Lamb MG, Sayegh R, Stanek JR, Auletta JJ. COVID-19 in immunocompromised patients: A systematic review of cancer, hematopoietic cell and solid organ transplant patients. J Infect 2021;82:329-38. [PMID: 33549624 DOI: 10.1016/j.jinf.2021.01.022] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 11.0] [Reference Citation Analysis]
121 Gabryszewski SJ, England RN, Sun D, Gentile TL, Hochgertel W, Jyonouchi S, Silverman M, Zaoutis T, Sullivan KE, Henrickson SE. Self-Limited COVID-19 in a Patient with Artemis Hypomorphic SCID. J Clin Immunol 2021;41:1745-7. [PMID: 34420125 DOI: 10.1007/s10875-021-01093-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
122 Shafiekhani M, Shahabinezhad F, Niknam T, Tara SA, Haem E, Mardani P, Zare Z, Jafarian S, Mirzad Jahromi K, Arabsheybani S, Moeini YS, Alavi J, Jalali SS, Salimi M, Shahriarirad R, Malekhosseini SA. Evaluation of the therapeutic regimen in COVID-19 in transplant patients: where do immunomodulatory and antivirals stand? Virol J 2021;18:228. [PMID: 34809657 DOI: 10.1186/s12985-021-01700-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
123 Yaneske E, Zampieri G, Bertoldi L, Benvenuto G, Angione C. Genome-scale metabolic modelling of SARS-CoV-2 in cancer cells reveals an increased shift to glycolytic energy production. FEBS Lett 2021;595:2350-65. [PMID: 34409594 DOI: 10.1002/1873-3468.14180] [Reference Citation Analysis]
124 Pawlowski C, Venkatakrishnan AJ, Ramudu E, Kirkup C, Puranik A, Kayal N, Berner G, Anand A, Barve R, O'Horo JC, Badley AD, Soundararajan V. Pre-existing conditions are associated with COVID-19 patients' hospitalization, despite confirmed clearance of SARS-CoV-2 virus. EClinicalMedicine 2021;34:100793. [PMID: 33778434 DOI: 10.1016/j.eclinm.2021.100793] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
125 Kandeel EZ, Refaat L, Abdel-Fatah R, Samra M, Bayoumi A, Abdellateif MS, Abdel-Hady H, Ali M, Khafagy M. Could COVID-19 induce remission of acute leukemia? Hematology 2021;26:870-3. [PMID: 34719343 DOI: 10.1080/16078454.2021.1992117] [Reference Citation Analysis]
126 Xu AM, Li D, Ebinger JE, Mengesha E, Elyanow R, Gittelman RM, Chapman H, Joung S, Botwin GJ, Pozdnyakova V, Debbas P, Mujukian A, Prostko JC, Frias EC, Stewart JL, Horizon AA, Merin N, Sobhani K, Figueiredo JC, Cheng S, Kaplan IM, Mcgovern DPB, Merchant A, Melmed GY, Braun J. Differences in SARS-CoV-2 Vaccine Response Dynamics Between Class-I- and Class-II-Specific T-Cell Receptors in Inflammatory Bowel Disease. Front Immunol 2022;13:880190. [DOI: 10.3389/fimmu.2022.880190] [Reference Citation Analysis]
127 Liu BM, Hill HR. Role of Host Immune and Inflammatory Responses in COVID-19 Cases with Underlying Primary Immunodeficiency: A Review.J Interferon Cytokine Res. 2020;40:549-554. [PMID: 33337932 DOI: 10.1089/jir.2020.0210] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
128 Gin LE, Guerrero FA, Brownell SE, Cooper KM, Momsen J. COVID-19 and Undergraduates with Disabilities: Challenges Resulting from the Rapid Transition to Online Course Delivery for Students with Disabilities in Undergraduate STEM at Large-Enrollment Institutions. LSE 2021;20:ar36. [DOI: 10.1187/cbe.21-02-0028] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
129 Ko KKK, Yingtaweesittikul H, Tan TT, Wijaya L, Cao DY, Goh SS, Abdul Rahman NB, Chan KXL, Tay HM, Sim JHC, Chan KS, Oon LLE, Nagarajan N, Suphavilai C. Emergence of SARS-CoV-2 Spike Mutations during Prolonged Infection in Immunocompromised Hosts. Microbiol Spectr 2022;:e0079122. [PMID: 35543562 DOI: 10.1128/spectrum.00791-22] [Reference Citation Analysis]
130 Elsamany S, Elbaiomy M, Zeeneldin A, Tashkandi E, Hassanin F, Abdelhafeez N, O Al-Shamsi H, Bukhari N, Elemam O. Suggested Modifications to the Management of Patients With Breast Cancer During the COVID-19 Pandemic: Web-Based Survey Study. JMIR Cancer 2021;7:e27073. [PMID: 34726611 DOI: 10.2196/27073] [Reference Citation Analysis]
131 Jamshidi E, Babajani A, Soltani P, Niknejad H. Proposed Mechanisms of Targeting COVID-19 by Delivering Mesenchymal Stem Cells and Their Exosomes to Damaged Organs. Stem Cell Rev Rep 2021;17:176-92. [PMID: 33432484 DOI: 10.1007/s12015-020-10109-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 10.0] [Reference Citation Analysis]
132 Desimmie BA, Raru YY, Awadh HM, He P, Teka S, Willenburg KS. Insights into SARS-CoV-2 Persistence and Its Relevance. Viruses 2021;13:1025. [PMID: 34072390 DOI: 10.3390/v13061025] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
133 Borse S, Joshi M, Saggam A, Bhat V, Walia S, Marathe A, Sagar S, Chavan-Gautam P, Girme A, Hingorani L, Tillu G. Ayurveda botanicals in COVID-19 management: An in silico multi-target approach. PLoS One 2021;16:e0248479. [PMID: 34115763 DOI: 10.1371/journal.pone.0248479] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
134 Glidden C, Howden K, Romanescu RG, Hatala A, Scott I, Deleemans JM, Chalifour K, Eaton G, Gupta AA, Bolton JM, Garland SN, Mahar AL, Oberoi S. Psychological distress and experiences of Adolescents and Young Adults with cancer during the COVID-19 pandemic: A cross-sectional survey. Psychooncology 2022. [PMID: 34989053 DOI: 10.1002/pon.5849] [Reference Citation Analysis]
135 Arias-Murillo YR, Benavides-V CA, Salinas-N MA, Osorio-Arango K, Plazas-Sierra C, Cortés JA. SARS-CoV2/COVID-19 Infection in Transplant Recipients and in Patients on the Organ Transplant Waiting List in Colombia. Transplant Proc 2021;53:1237-44. [PMID: 33558085 DOI: 10.1016/j.transproceed.2020.12.003] [Reference Citation Analysis]
136 Greco R, Alexander T, Burman J, Del Papa N, de Vries-Bouwstra J, Farge D, Henes J, Kazmi M, Kirgizov K, Muraro PA, Ricart E, Rovira M, Saccardi R, Sharrack B, Snarski E, Withers B, Jessop H, Boglione C, Kramer E, Badoglio M, Labopin M, Orchard K, Corbacioglu S, Ljungman P, Mikulska M, De la Camara R, Snowden JA; European Society for Blood and Marrow Transplantation (EBMT) Autoimmune Diseases Working Party (ADWP), Infectious Diseases Working Party (IDWP), Pediatric Working Party (PWP), Joint Accreditation Committee of the International Society for Cellular Therapy (ISCT) and EBMT (JACIE), EBMT Nurses Group and Patient Advocacy Committee. Hematopoietic stem cell transplantation for autoimmune diseases in the time of COVID-19: EBMT guidelines and recommendations. Bone Marrow Transplant 2021;56:1493-508. [PMID: 34031556 DOI: 10.1038/s41409-021-01326-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
137 Iftikhar A, Islam M, Shepherd S, Jones S, Ellis I. Is RAS the Link Between COVID-19 and Increased Stress in Head and Neck Cancer Patients? Front Cell Dev Biol 2021;9:714999. [PMID: 34336866 DOI: 10.3389/fcell.2021.714999] [Reference Citation Analysis]
138 Golbets E, Kaplan A, Shafat T, Yagel Y, Jotkowitz A, Awesat J, Barski L. Secondary organizing pneumonia after recovery of mild COVID-19 infection. J Med Virol 2022;94:417-23. [PMID: 34581458 DOI: 10.1002/jmv.27360] [Reference Citation Analysis]
139 deKay JT, Emery IF, Rud J, Eldridge A, Lord C, Gagnon DJ, May TL, Herrera VLM, Ruiz-Opazo N, Riker RR, Sawyer DB, Ryzhov S, Seder DB. DEspRhigh neutrophils are associated with critical illness in COVID-19. Sci Rep 2021;11:22463. [PMID: 34789851 DOI: 10.1038/s41598-021-01943-7] [Reference Citation Analysis]
140 Luxi N, Giovanazzi A, Capuano A, Crisafulli S, Cutroneo PM, Fantini MP, Ferrajolo C, Moretti U, Poluzzi E, Raschi E, Ravaldi C, Reno C, Tuccori M, Vannacci A, Zanoni G, Trifirò G; Ilmiovaccino COVID19 collaborating group. COVID-19 Vaccination in Pregnancy, Paediatrics, Immunocompromised Patients, and Persons with History of Allergy or Prior SARS-CoV-2 Infection: Overview of Current Recommendations and Pre- and Post-Marketing Evidence for Vaccine Efficacy and Safety. Drug Saf 2021;44:1247-69. [PMID: 34739716 DOI: 10.1007/s40264-021-01131-6] [Reference Citation Analysis]
141 Wen XS, Jiang D, Gao L, Zhou JZ, Xiao J, Cheng XC, He B, Chen Y, Lei P, Tan XW, Qin S, Zhang DY. Clinical characteristics and predictive value of lower CD4+T cell level in patients with moderate and severe COVID-19: a multicenter retrospective study. BMC Infect Dis 2021;21:57. [PMID: 33435865 DOI: 10.1186/s12879-020-05741-w] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
142 Islam JY, Vidot DC, Havanur A, Camacho-Rivera M. Preventive Behaviors and Mental Health-Related Symptoms Among Immunocompromised Adults During the COVID-19 Pandemic: An Analysis of the COVID Impact Survey. AIDS Res Hum Retroviruses 2021;37:304-13. [PMID: 33626959 DOI: 10.1089/AID.2020.0302] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
143 Meyer KC, Avery RK. Optimizing virus protection in lung transplant recipients: Don't drop the ball. Am J Transplant 2021;21:2633-4. [PMID: 33866667 DOI: 10.1111/ajt.16609] [Reference Citation Analysis]
144 Zhang J, Zhang J, Tao Z. Effect of Comorbid Diabetes on Clinical Characteristics of COVID-19 Patients Infected by the Wild-Type or Delta Variant of SARS-CoV-2. Front Endocrinol 2022;13:861443. [DOI: 10.3389/fendo.2022.861443] [Reference Citation Analysis]
145 Serrano Martins M, Pimentel F, Costa W, Fernandes C. COVID-19 in a Patient Newly Diagnosed with AIDS: Asymptomatic Disease. Eur J Case Rep Intern Med 2021;8:002204. [PMID: 33585339 DOI: 10.12890/2021_002204] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
146 Nelli F, Fabbri A, Panichi V, Giannarelli D, Topini G, Giron Berrios JR, Virtuoso A, Marrucci E, Mazzotta M, Schirripa M, Signorelli C, Chilelli MG, Primi F, Silvestri MA, Ruggeri EM. Peripheral lymphocyte subset counts predict antibody response after SARS-CoV-2 mRNA-BNT162b2 vaccine in cancer patients: results from the Vax-On-Profile study. International Immunopharmacology 2022. [DOI: 10.1016/j.intimp.2022.108774] [Reference Citation Analysis]
147 Wagner A, Garner-spitzer E, Schötta A, Orola M, Wessely A, Zwazl I, Ohradanova-repic A, Weseslindtner L, Tajti G, Gebetsberger L, Kratzer B, Tomosel E, Kutschera M, Tobudic S, Pickl WF, Kundi M, Stockinger H, Novacek G, Reinisch W, Zielinski C, Wiedermann U. SARS-CoV-2-mRNA Booster Vaccination Reverses Non-Responsiveness and Early Antibody Waning in Immunocompromised Patients – A Phase Four Study Comparing Immune Responses in Patients With Solid Cancers, Multiple Myeloma and Inflammatory Bowel Disease. Front Immunol 2022;13:889138. [DOI: 10.3389/fimmu.2022.889138] [Reference Citation Analysis]